scholarly journals In Silico Investigation of Traditional Chinese Medicine for Potential Lead Compounds as SPG7 Inhibitors against Coronary Artery Disease

Molecules ◽  
2016 ◽  
Vol 21 (5) ◽  
pp. 588 ◽  
Author(s):  
Kuen-Bao Chen ◽  
Kuan-Chung Chen ◽  
Ya-Lin Chang ◽  
Kun-Lung Chang ◽  
Pei-Chun Chang ◽  
...  
Keyword(s):  
Coronary Artery Disease ◽  
Coronary Artery ◽  
Chinese Medicine ◽  
Traditional Chinese Medicine ◽  
In Silico ◽  
Lead Compounds ◽  
Artery Disease

scholarly journals Expert Survey on the Prevention and Treatment Situation of Traditional Chinese Medicine for Coronary Artery Disease

2015 ◽  
Vol 06 (02) ◽  
pp. 109-114 ◽  
Author(s):  
Ying-Fei Bi ◽  
Jing-Yuan Mao ◽  
Xian-Liang Wang ◽  
Zhi-Qiang Zhao ◽  
Bin Li ◽  
...  
Keyword(s):  
Coronary Artery Disease ◽  
Coronary Artery ◽  
Chinese Medicine ◽  
Traditional Chinese Medicine ◽  
Expert Survey ◽  
Treatment Situation ◽  
Prevention And Treatment ◽  
Artery Disease

scholarly journals Traditional Chinese Medicine for Coronary Artery Disease Treatment: Clinical Evidence From Randomized Controlled Trials

2021 ◽  
Vol 8 ◽  
Author(s):  
Bo Liang ◽  
Ning Gu
Keyword(s):  
Coronary Artery Disease ◽  
Coronary Artery ◽  
Chinese Medicine ◽  
Traditional Chinese Medicine ◽  
Randomized Controlled Trials ◽  
Controlled Trials ◽  
Jadad Score ◽  
Randomized Controlled ◽  
Prevention And Treatment ◽  
Artery Disease

Traditional Chinese medicine has a history of more than 2,000 years and has been widely used in clinical practice. However, due to the lack of a reliable scientific basis, the role of traditional Chinese medicine in the prevention and treatment of coronary artery disease is not clear. At present, the existing randomized controlled trials about traditional Chinese medicine for coronary artery disease have defects, small sample sizes, and different results, so it is difficult to make a clear conclusion on the actual advantages and disadvantages of traditional Chinese medicine. In this review, the efficacy and safety of traditional Chinese medicine in the prevention and treatment of coronary artery disease were systematically evaluated through randomized controlled trials, most of which were double-blind trials. We reviewed 17 randomized controlled trials that included a total of 11,726 coronary artery disease patients. The methodological quality of the trials was generally high, with nine (52.94%) having a modified Jadad score of 7 and only three (17.65%) having a modified Jadad score of <3. There are 16 trials (94.12%) reporting safety; the safety of traditional Chinese medicine seems not to be inferior to that of mimetic, placebo, or western medications. Moreover, the results from 17 randomized controlled trials (100.00%) showed that traditional Chinese medicine can be applied as a complementary and alternative method to the primary and secondary prevention of coronary artery disease, and only six trials (35.29%) described adverse cardiovascular events specifically. However, it is necessary to assess the safety and efficacy of traditional Chinese medicine in treating coronary artery disease with long-term hard endpoints.

scholarly journals In-silico studies of HMG-Co A reductase inhibitors present in fruits of Withania coagulans Dunal (Solanaceae)

2020 ◽  
Vol 19 (2) ◽  
pp. 305-312
Author(s):  
Tooba Lateef ◽  
Sadaf Naeem ◽  
Shamim A. Qureshi
Keyword(s):  
Coronary Artery Disease ◽  
Coronary Artery ◽  
In Silico ◽  
Chemical Constituents ◽  
Hmg Coa Reductase ◽  
Docking Score ◽  
Molegro Virtual Docker ◽  
Withania Coagulans ◽  
Artery Disease ◽  
Coa Reductase

Purpose: To evaluate the antihypercholesterolemic effect of chemical constituents of W. coagulans by determining inhibitory effect of the compounds against HMG-CoA reductase, using in-silico methods. Method: Docking simulations of twenty-one chemical constituents, found in the fruits of W. coagulans were performed against HMGCR(PDB ID: 2Q1L) using Molegro Virtual Docker software. The best docked poses were then selected, based on the docking score and amino acids involved in the interaction within the ligand and active site of protein. Results: Five compounds viz. Coagulin D (comp no. 11), Ergosta-5,25-diene-3β,24ε-diol (comp no. 13), Withacoagulin (comp no. 15), and Withaferin (comp no. 16), showed the highest MolDock scores. These compounds with highest docking score, also formed hydrogen bond interactions with His (752), Lys (692, 735), Asp (690), Glu (559) within the binding site of HMG-CoA reductase, thus, halting enzyme activity. Whereas, Withanolide D (comp no. 17) with high MolDock score did not show hydrogen bonding interactions. Conclusion: The high MolDock score and maximum binding with catalytic region of the enzyme indicate that compounds selected from the fruits of W. coagulans are potential blockers of HMG-CoA reductase. Thus, the compounds may be useful for the management of hypercholesterolemia, which untreated, often leads to coronary artery disease. Keywords: Withania coagulans, Coronary artery disease, HMG-CoA reductase, Molegro virtual docker, Hypercholesterolemia, In silico studies

Sign in / Sign up

Export Citation Format

Share Document